Get started
Editas Medicine Inc.Editas Medicine Inc.Editas Medicine Inc.

Editas Medicine Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Forecast Seasonals

8EM chart


Full chart

8EM upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪238.61 M‬ EUR
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−2.3010 EUR
Net income (FY)
‪−138.82 M‬ EUR
Revenue (FY)
‪70.78 M‬ EUR
Shares float
‪81.77 M‬
Beta (1Y)
2.20

About Editas Medicine, Inc.


Sector
Health Technology
Industry
Biotechnology
CEO
Gilmore O’Neill
Website
editasmedicine.com
Headquarters
Cambridge
Founded
2013
FIGI
BBG00C5XQ159
Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

8EM news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


Depending on the exchange, the stock ticker may vary. For instance, on SWB exchange Editas Medicine Inc. stocks are traded under the ticker 8EM.
We've gathered analysts' opinions on Editas Medicine Inc. future price: according to them, 8EM price has a max estimate of 13.99 EUR and a min estimate of 3.73 EUR. Watch 8EM chart and read a more detailed Editas Medicine Inc. stock forecast: see what analysts think of Editas Medicine Inc. and suggest that you do with its stocks.
8EM reached its all-time high on Jan 11, 2021 with the price of 75.4800 EUR, and its all-time low was 2.5900 EUR and was reached on Nov 5, 2024. View more price dynamics on 8EM chart.
See other stocks reaching their highest and lowest prices.
Yes, you can track Editas Medicine Inc. financials in yearly and quarterly reports right on TradingView.
Editas Medicine Inc. is going to release the next earnings report on Feb 26, 2025. Keep track of upcoming events with our Earnings Calendar.
8EM earnings for the last quarter are −0.67 EUR per share, whereas the estimation was −0.67 EUR resulting in a −0.40% surprise. The estimated earnings for the next quarter are −0.34 EUR per share. See more details about Editas Medicine Inc. earnings.
Editas Medicine Inc. revenue for the last quarter amounts to ‪54.79 K‬ EUR, despite the estimated figure of ‪3.53 M‬ EUR. In the next quarter, revenue is expected to reach ‪27.22 M‬ EUR.
8EM net income for the last quarter is ‪−55.81 M‬ EUR, while the quarter before that showed ‪−63.12 M‬ EUR of net income which accounts for 11.58% change. Track more Editas Medicine Inc. financial stats to get the full picture.
No, 8EM doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 14, 2024, the company has 265.00 employees. See our rating of the largest employees — is Editas Medicine Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Editas Medicine Inc. EBITDA is ‪−199.95 M‬ EUR, and current EBITDA margin is −208.80%. See more stats in Editas Medicine Inc. financial statements.
Like other stocks, 8EM shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Editas Medicine Inc. stock right from TradingView charts — choose your broker and connect to your account.